Status:

UNKNOWN

Factor Replacement in Surgery

Lead Sponsor:

University Health Network, Toronto

Conditions:

Bleeding in Cardiac Surgery

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is a multicentre, randomized, active-control, pragmatic, Phase 2 pilot study in adult cardiac surgery patients. Two Canadian hospitals will participate, and it is estimated that the study will ta...

Eligibility Criteria

Inclusion

  • Patients undergoing any index cardiac surgery with or without CPB in whom coagulation factor replacement with PCC or FP is ordered in the operating room for:
  • Management of bleeding, or
  • Anticipated bleeding in a patient who has
  • been on-pump for \>2 hours, or
  • undergone a complex procedure (e.g., ACB + AVR). Coagulation factor deficiency must either be known to exist (as indicated by elevated EXTEM clotting time \[CT\] or international normalized ratio \[INR\]), or be suspected based on the clinical situation.

Exclusion

  • Patients who meet any of the following criteria are not eligible for the study:
  • Undergoing heart transplantation, insertion or removal of ventricular assist devices (not including intra-aortic balloon pump \[IABP\]), or repair of thoracoabdominal aneurysm
  • Critical state immediately before emergency surgery with high probability of death within 24 hours of surgery (e.g., acute aortic dissection, cardiac arrest within 24 hours before start of surgery)
  • History of heparin induced thrombocytopenia
  • Last preoperative INR \>1.5 and patient on warfarin
  • Taken dabigatran, rivaroxaban, apixaban, or edoxaban within 48 hours of start of surgery
  • Administered PCC or FP within 48 hours before start of surgery
  • History of severe allergic reaction to PCC or FP
  • Refusal of allogeneic blood products due to religious or other reasons
  • Known pregnancy

Key Trial Info

Start Date :

September 24 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2020

Estimated Enrollment :

103 Patients enrolled

Trial Details

Trial ID

NCT04114643

Start Date

September 24 2019

End Date

December 31 2020

Last Update

November 3 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sunnybrook Health Science Centre

Toronto, Ontario, Canada, M4N 3M5